Your browser doesn't support javascript.
loading
MiR126-targeted-nanoparticles combined with PI3K/AKT inhibitor as a new strategy to overcome melanoma resistance.
Arasi, Maria Beatrice; De Luca, Gabriele; Chronopoulou, Laura; Pedini, Francesca; Petrucci, Eleonora; Flego, Michela; Stringaro, Annarita; Colone, Marisa; Pasquini, Luca; Spada, Massimo; Lulli, Valentina; Perrotta, Maria Chiara; Calin, George Adrian; Palocci, Cleofe; Biffoni, Mauro; Felicetti, Federica; Felli, Nadia.
Afiliación
  • Arasi MB; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
  • De Luca G; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
  • Chronopoulou L; Department of Chemistry, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy; Research Center for Applied Sciences to the safeguard of Environment and Cultural Heritage (CIABC) Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy.
  • Pedini F; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
  • Petrucci E; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
  • Flego M; National Center for Global Health, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
  • Stringaro A; National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
  • Colone M; National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
  • Pasquini L; Core Facilities, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
  • Spada M; Center of Animal Research and Welfare, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
  • Lulli V; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
  • Perrotta MC; Department of Chemistry, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy.
  • Calin GA; Translational Molecular Pathology, MD Anderson Cancer Center, Texas State University, 1515 Holcombe Blvd, Houston, TX 77030, USA; The RNA Interference and Non-coding RNA Center, MD Anderson Cancer Center, Texas State University, Houston, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Palocci C; Department of Chemistry, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy; Research Center for Applied Sciences to the safeguard of Environment and Cultural Heritage (CIABC) Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy.
  • Biffoni M; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
  • Felicetti F; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
  • Felli N; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy. Electronic address: nadia.felli@iss.it.
Mol Ther ; 32(1): 152-167, 2024 Jan 03.
Article en En | MEDLINE | ID: mdl-37990493
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: MicroARNs / Melanoma Límite: Animals / Humans Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2024 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: MicroARNs / Melanoma Límite: Animals / Humans Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2024 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos